Top Story

Morning Read: Robert Califf confirmed to lead FDA, Verily joins the president’s precision medicine pilot

Plus, biopharma CEOs grow bearish about their ability to raise new capital, Hollywood Presbyterian ransomware attack may be just the beginning and incoming Dana-Farber CEO is excited for the future.

WASHINGTON, DC - NOVEMBER 17: Dr. Robert Califf testifies during his nomination hearing before the Senate Health, Education, Labor and Pensions Committee November 17, 2015 in Washington, DC. Califf is U.S. President Barack Obama's nominee to be the next commissioner of the Food and Drug Administration. (Photo by Win McNamee/Getty Images)

TOP STORIES

The Senate on Wednesday confirmed Dr. Robert Califf as new commissioner of the FDA. Despite some vocal opposition from a handful of senators early on in the nomination process, Califf cleared the Senate by an 89-4 margin. Presidential candidate Sen. Bernie Sanders (D-Vermont) was one of the “no” votes. Sen. Lisa Murkowski (R-Alaska) had stalled the nomination earlier, but ultimately voted to confirm. — The Washington Post

Verily, formerly Google Life Sciences, is joining Vanderbilt University in a pilot program that launches President Obama’s Precision Medicine Initiative. The program will enroll 79,000 volunteers this year to supply personal data to look at not only at genetic factors but also the role of environmental exposures and their impact on genetic predispositions. – Reuters

LIFE SCIENCES

Look for lots more information around Obama’s Precision Medicine Initiative, but here’s one bit: Inova Health System has launched a $100 million venture fund focused on precision medicine. – Washington Business Journal

Tara Therapeutics, which has a osteoperosis drug application in with the FDA, has raised $2 million. – Philadelphia Business Journal

presented by

Meet the judge, a former wannabe scientist, who is overseeing the CRISPR patent dispute case. – STAT

A win for AstraZeneca: Acerta Pharma’s acalabrutinib (AZ holds 55 percent of the company) got a European recommendation as an orphan product for chronic lymphocytic leukaemia or small lymphocytic lymphoma, mantle cell lymphoma and lymphoplasmacytic lymphoma. – Reuters

Genentech’s lucrative Cabilly patents for manufacturing antibodies, which date to the 1980s, face their toughest challenge to date. — San Francisco Business Times

Biopharma CEOs are losing confidence in their ability to raise new capital in the next 18 months, according to a new survey. — Triangle Business Journal

Boston Scientific’s Brazil offices were searched as part of a government probe of a medical device government contract. – MassDevice

Hedge fund Krensavage Partners has bought 6 percent of RTI Surgical and wants to reshape the company’s board. — MassDevice

Mapp Biopharmaceutical’s ZMapp Ebola drug “showed promise” in a clinical trial, but didn’t demonstrate any statistically significant benefits. — FierceBiotech

PAYERS-PROVIDERS

“It’s a revolutionary time for cancer therapy,” said Dr. Laurie Glimcher, the newly named successor to retiring Dana-Farber Cancer Institute CEO Dr. Edward Benz. — Boston Business Journal

Cleveland Clinic had its best financial year in its long history, reporting operating income of $481 million for 2015. CEO Dr. Toby Cosgrove cited ongoing efficiency gains on both the business and clinical sides. — The Plain Dealer

A self-serving but peer-reviewed study showed that MDVIP’s concierge model of preventive primary care saves money and improves health management. — Business Wire

The University of Washington School of Medicine and Gonzaga University are partnering on a medical education program in Spokane, Washington. — Puget Sound Business Journal

TECHNOLOGY

An investment from UPMC has pushed Vivify Health’s total investment to more than $34 million (it focuses on patient monitoring). – MobiHealthNews

The ransomware attack on Hollywood Presbyterian Medical Center is an early example of why healthcare may be the “next big hunting arena for cyber criminals.” — Knowledge@Wharton

CommonWell Health Alliance has extended cross-vendor interoperability services to post-acute care. — Business Wire

WebMD could join the healthcare price transparency and telehealth business? – MobiHealthNews

E-prescribing startup CenterX, of Madison, Wisconsin, has landed $3.3 million in new investments. — Xconomy

Get ready for next week’s HIMSS16 mega-conference with this list of official hashtags for social media. — HIMSS

POLITICS

Find out what the presidential contenders have to say about mental health — and then ask why more don’t have detailed action plans for addressing the problem. — NBC News

Did late Supreme Court Justice Antonin Scalia die because he wasn’t using his CPAP machine? — The Washington Post

A LITTLE BIT EXTRA

Potheads, stop going to Colorado to smoke legally. You might save yourself a trip to the ER. — Reuters

Photo Win McNamee/Getty Images